CD68 and breast cancer: In breast cancer, MMP11 expression was considered as a biomarker for prognosis [80], and correlated with a high CD68/(CD3 + CD20) ratio in CD68+ macrophages [81], which caused the polarisation of macrophages in the tumour centre, resulting in a higher metastatic phenotype [82].